Compounds > triazoles
Page last updated: 2024-08-24

triazoles and entinostat

triazoles has been researched along with entinostat in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Brodie, AM; Chumsri, S; Goloubeva, O; Nguyen, N; Sabnis, GJ; Sukumar, S1
Brodie, AM; Chumsri, S; Howes, T; Sabnis, GJ1
Brodie, AH; Goloubeva, OG; Kazi, AA; Sabnis, GJ; Shah, P1
Brodie, A; Chumsri, S; Goloubeva, O; Kazi, A; Rosenblatt, P; Sabnis, GJ; Schech, AJ; Shah, P; Yu, S1
Babaei, P; Badrikoohi, M; Esmaeili-Bandboni, A1

Other Studies

5 other study(ies) available for triazoles and entinostat

ArticleYear
Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole.
    Cancer research, 2011, Mar-01, Volume: 71, Issue:5

    Topics: Animals; Antineoplastic Agents; Aromatase; Benzamides; Blotting, Western; Estrogen Receptor alpha; Female; Humans; Immunohistochemistry; Letrozole; Mice; Mice, Nude; Nitriles; Oligonucleotide Array Sequence Analysis; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Up-Regulation; Xenograft Model Antitumor Assays

2011
Aromatase inhibitors and xenograft studies.
    Steroids, 2011, Volume: 76, Issue:8

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Benzamides; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Letrozole; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Nitriles; Phosphorylation; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Trastuzumab; Triazoles; Xenograft Model Antitumor Assays

2011
HDAC inhibitor entinostat restores responsiveness of letrozole-resistant MCF-7Ca xenografts to aromatase inhibitors through modulation of Her-2.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:12

    Topics: Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Benzamides; Disease Models, Animal; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Letrozole; MAP Kinase Signaling System; MCF-7 Cells; Mice; Nitriles; Pyridines; Receptor, ErbB-2; RNA Stability; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays

2013
Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer.
    Breast cancer research and treatment, 2015, Volume: 152, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzamides; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Histone Deacetylase Inhibitors; Humans; Letrozole; Mice, Nude; Nitriles; Pyridines; Receptor, ErbB-2; Tretinoin; Triazoles; Xenograft Model Antitumor Assays

2015
Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats.
    Brain research bulletin, 2022, Volume: 179

    Topics: Alzheimer Disease; Animals; Azepines; Behavior, Animal; Benzamides; CREB-Binding Protein; Disease Models, Animal; Drug Therapy, Combination; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Male; Memory Disorders; Nuclear Proteins; Pyridines; Random Allocation; Rats; Rats, Wistar; Transcription Factors; Triazoles; Tumor Necrosis Factor-alpha

2022